Is a complete QNRX research report available?

No complete published report is available for Quoin Pharmaceuticals, Ltd. (QNRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · USD

$4.40

+0.12 (+2.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first QNRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.8M
Net income (ttm)	-17M
EPS (ttm)	-$10.4
Shares out	2M
Volume	40,083
Beta	1.66
Price target	$21.4	+386.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -17M
EPS (ttm): -$10.4
Market cap: 8.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All QNRX indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001671502
Company name	Quoin Pharmaceuticals, Ltd.
Country	United States
Country code	US
Cusip	74907L409
Employees	6
Employees Change	1%
Employees Change Percent	20
Enterprise value	$-3.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74907L4095
Last refreshed	2026-07-31
Market cap	$8.8M
Market cap category	Nano-Cap
Price	$4.4
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	QNRX
Website	https://quoinpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-201.9%
P/B ratio	0.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-17M
Net Income Growth Years	0%
Profit Per Employee	$-2.8M
ROA	-76.2
Roa5y	-52.47
ROCE	-168.8
ROE	-231.2
ROIC	-111.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-43.68%
Cagr3y	-74.42%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$15.7M
Cash	$14M
Current Assets	$15.3M
Current Liabilities	$5.3M
Debt	$2.2M
Debt Equity	$0.25
Equity	$8.8M
Liabilities	$6.9M
Long Term Assets	$358,334
Long Term Liabilities	$1.6M
Net Cash	$11.9M
Net Cash By Market Cap	$141
Net Cash Growth	35.2%
Net Debt Equity	$-1.35
Tangible Book Value	$8.4M
Tangible Book Value Per Share	$4.29
WACC	10.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.87
Net Working Capital	$-3.5M
Quick ratio	2.63
Working Capital	$10M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-518.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-43.66%
200-day SMA	8.89
3Y total return	-98.33%
50-day SMA	4.52
50-day SMA vs 200-day SMA	50under200
All Time High	70,638.9
All Time High Change	-99.99%
All Time High Date	2021-10-29
All Time Low	3.25
All Time Low Change	35.38%
All Time Low Date	2026-06-23
ATR	0.33
Beta	1.66
Beta1y	-2.61
Beta2y	-0.92
Ch YTD	-69.51
High	4.4
High52	41.8
High52 Date	2025-10-10
High52ch	-89.47%
Low	3.99
Low52	3.25
Low52 Date	2026-06-23
Low52ch	35.39%
Ma50ch	-2.61%
Price vs 200-day SMA	-50.48%
RSI	49.43
RSI Monthly	2.86
RSI Weekly	38.33
Sharpe ratio	0.34x
Sortino ratio	0.82
Total Return	-518.76%
Tr YTD	-69.51
Tr1m	-3.3%
Tr1w	0.69%
Tr3m	-25.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$30
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-1.78
Operating Income	$-17.5M
Price target	$21.4
Price Target Change	$386
Price Target Change Top	$582

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,633,966%
Float Percent	81.36%
Net Borrowing	-600,000
Shares Insiders	2.63%
Shares Institutions	46.15%
Shares Out	2,008,417
Shares Qo Q	13.5%
Shares Yo Y	518.76%
Short Ratio	0.23
Short Shares	7.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-17,047,142
Average Volume	22,913.85x
Bv Per Share	4.47
Ch1m	-3.3
Ch1w	0.69
Ch1y	-43.66
Ch3m	-25.8
Ch3y	-98.33
Ch6m	-46.99
Change	2.92%
Change From Open	4.51
Close	4.28
Days Gap	-1.52
Depreciation Amortization	100,000
Dollar Volume	176,365.2
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-17.5M
EBITDA	$-17.4M
EPS	$-10.43
F Score	3
Financing CF	18,047,159
Fiscal Year End	December
Founded	2,018
Investing CF	-2,928,861
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-04-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	7.09
Ma150ch	-37.91%
Ma20	4.38
Ma20ch	0.36%
Net CF	-697,599
Next Earnings Date	2026-08-10
Open	4.21
Optionable	No
Position In Range	100
Post Close	4.4
Postmarket Change Percent	-1.36
Postmarket Price	$4.34
Price Date	2026-07-30
Ptbv Ratio	1
Relative Volume	1.75x
Share Based Comp	1,231,404
Tr6m	-46.99%
Us State	Virginia
Volume	40,083

Quoin Pharmaceuticals, Ltd. (QNRX)

Coverage state: Market snapshot only — no published research

Generate the first QNRX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · QNRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All QNRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on QNRX

Frequently asked questions